ATE154238T1 - Arzneimittel verzögerter wirkstoffabgabe - Google Patents
Arzneimittel verzögerter wirkstoffabgabeInfo
- Publication number
- ATE154238T1 ATE154238T1 AT93301139T AT93301139T ATE154238T1 AT E154238 T1 ATE154238 T1 AT E154238T1 AT 93301139 T AT93301139 T AT 93301139T AT 93301139 T AT93301139 T AT 93301139T AT E154238 T1 ATE154238 T1 AT E154238T1
- Authority
- AT
- Austria
- Prior art keywords
- release
- active ingredient
- delayed release
- medicinal products
- expected
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929203689A GB9203689D0 (en) | 1992-02-20 | 1992-02-20 | Pharmaceutical composition |
GB929209520A GB9209520D0 (en) | 1992-05-01 | 1992-05-01 | Pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE154238T1 true ATE154238T1 (de) | 1997-06-15 |
Family
ID=26300352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93301139T ATE154238T1 (de) | 1992-02-20 | 1993-02-17 | Arzneimittel verzögerter wirkstoffabgabe |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0557064B1 (de) |
JP (1) | JP3623805B2 (de) |
AT (1) | ATE154238T1 (de) |
DE (1) | DE69311394T2 (de) |
GB (1) | GB2264639B (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4318577A1 (de) * | 1993-06-04 | 1994-12-08 | Merck Patent Gmbh | Schmiermittelfreie, arzneimittelhaltige Tabletten |
US5965161A (en) * | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
AU5066101A (en) * | 2000-04-13 | 2001-10-30 | Synthon B.V. | Modified release formulations containing a hypnotic agent |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE795766A (fr) * | 1972-02-22 | 1973-08-22 | Lilly Co Eli | Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules |
FR2585246A1 (fr) * | 1985-07-26 | 1987-01-30 | Cortial | Procede d'obtention de formes pharmaceutiques solides a liberation prolongee |
GB8521350D0 (en) * | 1985-08-28 | 1985-10-02 | Euro Celtique Sa | Analgesic composition |
IL81419A0 (en) * | 1986-01-30 | 1987-08-31 | Syntex Inc | Long acting sustained release pharmaceutical compositions containing dihydropyridines and their preparation |
SE457326B (sv) * | 1986-02-14 | 1988-12-19 | Lejus Medical Ab | Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa |
GB8626098D0 (en) * | 1986-10-31 | 1986-12-03 | Euro Celtique Sa | Controlled release hydromorphone composition |
CA1323833C (en) * | 1987-04-28 | 1993-11-02 | Yatindra M. Joshi | Pharmaceutical compositions in the form of beadlets and method |
FR2620332A1 (fr) * | 1987-09-11 | 1989-03-17 | Squibb & Sons Inc | Composition pharmaceutique a forte teneur en medicament, et procede pour la preparer |
DE3929864A1 (de) * | 1989-09-08 | 1991-03-14 | Nordmark Arzneimittel Gmbh | Verfahren zur herstellung von theophyllin-pellets |
EP0418597A3 (en) * | 1989-09-21 | 1991-11-27 | American Cyanamid Company | Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form |
DE69111287T2 (de) * | 1990-04-18 | 1995-12-21 | Asahi Chemical Ind | Kugelförmige Keimkerne, kugelförmige Granulate sowie Verfahren zu deren Herstellung. |
GB2258810B (en) * | 1991-08-12 | 1996-01-31 | Euro Celtique Sa | Pharmaceutical combination formulation of diltiazem and hydrochlorothiazide |
US5273760A (en) * | 1991-12-24 | 1993-12-28 | Euroceltigue, S.A. | Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
-
1993
- 1993-02-17 JP JP05150793A patent/JP3623805B2/ja not_active Expired - Lifetime
- 1993-02-17 AT AT93301139T patent/ATE154238T1/de not_active IP Right Cessation
- 1993-02-17 DE DE69311394T patent/DE69311394T2/de not_active Expired - Lifetime
- 1993-02-17 EP EP93301139A patent/EP0557064B1/de not_active Expired - Lifetime
- 1993-02-17 GB GB9303132A patent/GB2264639B/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH0624964A (ja) | 1994-02-01 |
EP0557064B1 (de) | 1997-06-11 |
GB2264639A (en) | 1993-09-08 |
DE69311394D1 (de) | 1997-07-17 |
GB9303132D0 (en) | 1993-03-31 |
EP0557064A1 (de) | 1993-08-25 |
DE69311394T2 (de) | 1997-10-30 |
JP3623805B2 (ja) | 2005-02-23 |
GB2264639B (en) | 1996-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69311395D1 (de) | Sphäroidische Arzneimittelformulierung | |
DE69435295D1 (de) | Tramadolhaltiges Arzneimittel mit gesteuerter Wirkstoffabgabe | |
CA2179540A1 (en) | Accelerated release composition containing bromocriptine | |
IL111519A0 (en) | Sustained release tablets having an insoluble active ingredient therein and methods for the preparation thereof | |
RU94032150A (ru) | Лекарственное средство с замедленным высвобождением активно-действующего вещества | |
KR870002832A (ko) | 제약 조성물 | |
YU26102A (sh) | Nove farmaceutske smese antituberkuloznih lekova i postupak za njihovo dobijanje | |
HUT55220A (en) | Process for producing pharmaceutical composition suitable for systemic administration through the skin and comprising deprenyl as active ingredient | |
PT923934E (pt) | Formulacao de matriz de libertacao modificada de cefaclor e cefalexina | |
DE3872739D1 (de) | Arzneimittel mit langsamer freisetzung. | |
DK98088D0 (da) | Farmaceutisk formulering med forsinket frigivelse af den aktive bestanddel | |
ATE221372T1 (de) | Pharmazeutische zubereitung mit schneller freisetzung | |
WO2000010533A3 (en) | Compositions and methods for treating intracellular infections | |
HUT59319A (en) | Pharmaceutical compositions with controlled release of active ingredient and process for producing same | |
ATE154238T1 (de) | Arzneimittel verzögerter wirkstoffabgabe | |
UA40636C2 (uk) | Фармацевтична композиція для одержання стабільного порошку, яка містить як активний компонент асоціацію ацетилсаліцилової кислоти та метоклопраміду, фармацевтичний препарат у формі порошку та спосіб одержання цього препарату | |
ZA9610714B (en) | Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet | |
EP1072261A3 (de) | Felbinac enthaltendes Pflaster | |
CA2120001A1 (en) | Flavopereirine-based pharmaceutical composition and use thereof for treating hiv | |
EP0443028A4 (de) | Nicht einspritzbares karzinostatisches mittel zur vorbeugung der entzündung durch 5-fluoruracil und verfahren zur behandlung von krebs. | |
NO20011087D0 (no) | Farmasøytiske preparater inneholdende kalsiumvalproat med forsinket frisetting av aktiv bestanddel samt fremgangsmÕte for fremstilling derav | |
ATE110564T1 (de) | Pharmazeutische zusammensetzungen mit verzögerter freisetzung zur oralen verabreichung sowie deren herstellungsverfahren. | |
IE37288B1 (en) | Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children | |
IS3947A (is) | Amínósýru afleiður, aðferð til framleiðslu þeirraog notkunar sem lyfja | |
CA2099667A1 (en) | Agent for treating hepatic diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |